Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SFU Completes Installation of Electron Microscopes from FEI

Published: Tuesday, March 11, 2014
Last Updated: Monday, March 10, 2014
Bookmark and Share
SFU’s new multi-million-dollar Centre for Soft Materials now offers the most advanced suite of microscopes in Western Canada.

FEI has announced that it has completed the installation of a suite of high-end electron microscopes at Simon Fraser University’s (SFU) new Centre for Soft Materials. The systems installed include the Tecnai Osiris™ transmission electron microscope (TEM) and Helios™ DualBeam™ (scanning electron microscope/focused ion beam). These systems join several other FEI microscopes in the 4D LABS facility, Vancouver, British Columbia, where the new, multi-million dollar center is housed.

“To accommodate the unique needs of soft materials processing and characterization, SFU’s 4D LABS has partnered with Canada’s Western Economic Diversification, the Automotive Fuel Cell Cooperation, Systems for Research and FEI to create the Centre for Soft Materials,” said Byron Gates, associate professor and Canada research chair in surface chemistry, Department of Chemistry at SFU.

Gates continued, “We are implementing specialized microscope equipment and methods optimized for ‘soft’ materials that are easily damaged by high-energy particle beam analytical techniques. Materials in this vital class range from simple polymers and composites to cells and tissues. By improving our understanding of them we will be better able to design new materials and products for applications that include medicine, clean energy, information technology and many more.”

The Centre’s Helios DualBeam system offers cryogenic transfer and analysis capabilities. Its focused ion beam (FIB) can slice into the soft material with minimal damage and its SEM provides high-resolution images of the revealed cross-sectional surface for three-dimensional (3D) analysis.

The Osiris TEM provides a highly efficient way to analyze samples that are sensitive to particle beams by using fast, high-resolution imaging and optimized compositional analysis using a unique and patented X-ray detection system.

Cryogenic holders can also be used in the Osiris for inspection of samples while cooled. This combination of low-dose, fast, high-resolution imaging; 3D reconstruction; and elemental analysis provide a unique set of capabilities for soft material analysis that was previously unavailable to researchers in Western Canada.

According to Trisha Rice, vice president and general manager of the Materials Science Business Unit, Science Group, FEI, “We are delighted to complete the installation of the Osiris and Helios systems at SFU’s new research facility. Globally, there is increasing interest in engineering polymers and composite materials as replacements for existing materials used in electronics, automotive and other industrial materials applications. We expect these new microscopes to provide SFU researchers with the capabilities they need to understand and improve the performance of soft materials in real-world conditions. These new microscopes also give the students an opportunity for hands-on training in advanced microscopy systems.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Cancer Drug Target in Dual-Function Protein
Scientists at The Scripps Research Institute (TSRI) have identified a protein that launches cancer growth and appears to contribute to higher mortality in breast cancer patients.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!